The postoperative analgesic efficacy of liposomal bupivacaine versus long-acting local anaesthetics for peripheral nerve and field blocks: A systematic review and meta-analysis, with trial sequential analysis.
Journal
European journal of anaesthesiology
ISSN: 1365-2346
Titre abrégé: Eur J Anaesthesiol
Pays: England
ID NLM: 8411711
Informations de publication
Date de publication:
01 09 2023
01 09 2023
Historique:
medline:
3
8
2023
pubmed:
12
4
2023
entrez:
11
4
2023
Statut:
ppublish
Résumé
Liposomal bupivacaine is claimed by the manufacturer to provide analgesia for up to 72 h postoperatively. To compare the postoperative analgesic efficacy of liposomal bupivacaine versus long-acting local anaesthetics for peripheral nerve or field blocks. A systematic review and meta-analysis with trial sequential analysis. MEDLINE, Embase and Web of Science, among others, up to June 2022. We retrieved randomised controlled trials comparing liposomal bupivacaine versus bupivacaine, levobupivacaine or ropivacaine for peripheral nerve and field blocks after all types of surgery. Our primary endpoint was rest pain score (analogue scale 0 to 10) at 24 h. Secondary endpoints included rest pain score at 48 and 72 h, and morphine consumption at 24, 48 and 72 h. Twenty-seven trials including 2122 patients were identified. Rest pain scores at 24 h were significantly reduced by liposomal bupivacaine with a mean difference (95% CI) of -0.9 (-1.4 to -0.4), I2 = 87%, P < 0.001. This reduction in pain scores persisted at 48 h and 72 h with mean differences (95% CI) of -0.7 (-1.1 to -0.3), I2 = 82%, P = 0.001 and -0.7 (-1.1 to -0.3), I2 = 80%, P < 0.001, respectively. There were no differences in interval morphine consumption at 24 h ( P = 0.15), 48 h ( P = 0.15) and 72 h ( P = 0.07). The quality of evidence was moderate. There is moderate level evidence that liposomal bupivacaine reduces rest pain scores by 0.9 out of 10 units, when compared with long-acting local anaesthetics at 24 hours after surgery, and by 0.7 up to 72 hours after surgery.
Sections du résumé
BACKGROUND
Liposomal bupivacaine is claimed by the manufacturer to provide analgesia for up to 72 h postoperatively.
OBJECTIVES
To compare the postoperative analgesic efficacy of liposomal bupivacaine versus long-acting local anaesthetics for peripheral nerve or field blocks.
DESIGN
A systematic review and meta-analysis with trial sequential analysis.
DATA SOURCES
MEDLINE, Embase and Web of Science, among others, up to June 2022.
ELIGIBILITY CRITERIA
We retrieved randomised controlled trials comparing liposomal bupivacaine versus bupivacaine, levobupivacaine or ropivacaine for peripheral nerve and field blocks after all types of surgery. Our primary endpoint was rest pain score (analogue scale 0 to 10) at 24 h. Secondary endpoints included rest pain score at 48 and 72 h, and morphine consumption at 24, 48 and 72 h.
RESULTS
Twenty-seven trials including 2122 patients were identified. Rest pain scores at 24 h were significantly reduced by liposomal bupivacaine with a mean difference (95% CI) of -0.9 (-1.4 to -0.4), I2 = 87%, P < 0.001. This reduction in pain scores persisted at 48 h and 72 h with mean differences (95% CI) of -0.7 (-1.1 to -0.3), I2 = 82%, P = 0.001 and -0.7 (-1.1 to -0.3), I2 = 80%, P < 0.001, respectively. There were no differences in interval morphine consumption at 24 h ( P = 0.15), 48 h ( P = 0.15) and 72 h ( P = 0.07). The quality of evidence was moderate.
CONCLUSIONS
There is moderate level evidence that liposomal bupivacaine reduces rest pain scores by 0.9 out of 10 units, when compared with long-acting local anaesthetics at 24 hours after surgery, and by 0.7 up to 72 hours after surgery.
Identifiants
pubmed: 37038770
doi: 10.1097/EJA.0000000000001833
pii: 00003643-990000000-00077
doi:
Substances chimiques
Anesthetics, Local
0
Bupivacaine
Y8335394RO
Analgesics
0
Morphine
76I7G6D29C
Analgesics, Opioid
0
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
624-635Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2023 European Society of Anaesthesiology and Intensive Care. Unauthorized reproduction of this article is prohibited.
Références
Chou R, Gordon DB, de Leon-Casasola OA, et al. Management of postoperative pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists’ Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain 2016; 17:131–157.
Baeriswyl M, Kirkham KR, Jacot-Guillarmod A, et al. Efficacy of perineural vs systemic dexamethasone to prolong analgesia after peripheral nerve block: a systematic review and meta-analysis. Br J Anaesth 2017; 119:183–191.
Albrecht E, Kern C, Kirkham KR. A systematic review and meta-analysis of perineural dexamethasone for peripheral nerve blocks. Anaesthesia 2015; 70:71–83.
Albrecht E, Reynvoet M, Fournier N, et al. Dose-response relationship of perineural dexamethasone for interscalene brachial plexus block: a randomised, controlled, triple-blind trial. Anaesthesia 2019; 74:1001–1008.
Albrecht E, Chin KJ. Advances in regional anaesthesia and acute pain management: a narrative review. Anaesthesia 2020; 75: (Suppl 1): e101–e110.
Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022496s035lbl.pdf [Accessed 24 July 2022].
European Medicines Agency. European Medicines Agency. https://www.ema.europa.eu/en/documents/product-information/exparel-liposomal-epar-product-information_en.pdf . [Accessed 16 December 2022].
Hussain N, Brull R, Sheehy B, et al. Perineural liposomal bupivacaine is not superior to nonliposomal bupivacaine for peripheral nerve block analgesia. Anesthesiology 2021; 134:147–164.
Dinges H-C, Wiesmann T, Otremba B, et al. The analgesic efficacy of liposomal bupivacaine compared with bupivacaine hydrochloride for the prevention of postoperative pain: a systematic review and meta-analysis with trial sequential analysis. Reg Anesth Pain Med 2021; 46:490–498.
Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of healthcare interventions: checklist and explanations. Ann Intern Med 2015; 162:777–784.
Grape S, Kirkham KR, Albrecht E. Transversus abdominis plane block versus local anaesthetic wound infiltration for analgesia after caesarean section: a systematic review and meta-analysis with trial sequential analysis. Eur J Anaesth 2022; 39:244–251.
Grape S, Kirkham KR, Albrecht E. The analgesic efficacy of transversus abdominis plane block vs. wound infiltration after inguinal and infra-umbilical hernia repairs: a systematic review and meta-analysis with trial sequential analysis. Eur J Anaesth 2022; 39:611–618.
Cochrane Handbook for systematic reviews of interventions. https://training.cochrane.org/handbook/current . [Accessed 10 March 2022].
Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Me 2002; 21:1539–1558.
Choi SW, Lam DMH. Heterogeneity in meta-analyses. Comparing apples and oranges? Anaesthesia 2017; 72:532–534.
Carlisle JB. Systematic reviews: how they work and how to use them. Anaesthesia 2007; 62:702–707.
Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56:455–463.
Baessler AM, Moor M, Conrad DJ, et al. Single-shot liposomal bupivacaine reduces postoperative narcotic use following outpatient rotator cuff repair: a prospective, double-blinded, randomized controlled trial. J Bone Joint Surg 2020; 102:1985–1992.
Cox SG, Vicinanzo MG, Jacobs SM, et al. Liposomal bupivacaine suspension for pain control following ocular evisceration surgery. Ophthalmic Plast Reconstr Surg 2022; 38:263–265.
Dawes AM, Spencer CC, Guisse N, et al. A comparison of liposomal bupivacaine to standard ropivacaine used in interscalene blocks for patients undergoing total shoulder arthroplasty. J Shoulder Elbow Surg 2021; 31:117–124.
Dengler KL, Craig ER, DiCarlo-Meacham AM, et al. Preoperative pudendal block with liposomal and plain bupivacaine reduces pain associated with posterior colporrhaphy: a double-blinded, randomized controlled trial. Am J Obstet Gynecol 2021; 225:556e1–556e10.
Fafaj A, Krpata DM, Petro CC, et al. The efficacy of liposomal bupivacaine on postoperative pain following abdominal wall reconstruction: a randomized, double-blind placebo-controlled trial. Ann Surg 2022; 276:224–232.
Fidkowski CW, Choksi N, Alsaden M-R. A randomized-controlled trial comparing liposomal bupivacaine, plain bupivacaine, and the mixture of liposomal bupivacaine and plain bupivacaine in transversus abdominus plane block for postoperative analgesia for open abdominal hysterectomies. Can J Anesth 2021; 68:773–781.
Flaherty JM, Berg AA, Harrison A, et al. Comparing liposomal bupivacaine plus bupivacaine to bupivacaine alone in interscalene blocks for rotator cuff repair surgery: a randomized clinical trial. Reg Anesth Pain Med 2022.
Guerra L, Philip S, Lax EA, et al. Transversus abdominis plane blocks in laparoscopic colorectal surgery: better pain control and patient outcomes with liposomal bupivacaine than bupivacaine. Am Surg 2019; 85:1013–1016.
Ha AY, Keane G, Parikh R, et al. The analgesic effects of liposomal bupivacaine versus bupivacaine hydrochloride administered as a transversus abdominis plane block after abdominally based autologous microvascular breast reconstruction: a prospective, single-blind, randomized, controlled trial. Plast Reconstru Surg 2019; 144:35–44.
Hattrup SJ, Chung AS, Rosenfeld DM, et al. Liposomal bupivacaine interscalene nerve block in shoulder arthroplasty is not superior to plain bupivacaine: a double-blinded prospective randomized control trial. J Shoulder Eldow Surg 2021; 30:587–598.
Hubler CP, Bevil KM, Greiner JJ, et al. Liposomal bupivacaine versus standard bupivacaine in the adductor canal for total knee arthroplasty: a randomized, controlled trial. Orthopedics 2021; 44:249–255.
Hungerford M, Neubauer P, Ciotola J, et al. Liposomal bupivacaine vs ropivacaine for adductor canal blocks in total knee arthroplasty: a prospective randomized trial. J Arthroplast 2021; 36:3915–3921.
Hutchins J, Delaney D, Vogel RI, et al. Ultrasound guided subcostal transversus abdominis plane (TAP) infiltration with liposomal bupivacaine for patients undergoing robotic assisted hysterectomy: a prospective randomized controlled study. Gynecol Oncol 2015; 138:609–613.
Hutchins JL, Kesha R, Blanco F, et al. Ultrasound-guided subcostal transversus abdominis plane blocks with liposomal bupivacaine vs. nonliposomal bupivacaine for postoperative pain control after laparoscopic hand-assisted donor nephrectomy: a prospective randomised observer-blinded study. Anaesthesia 2016; 71:930–937.
Kim DH, Liu J, Beathe JC, et al. Interscalene brachial plexus block with liposomal bupivacaine versus standard bupivacaine with perineural dexamethasone: a noninferiority trial. Anesthesiology 2022; 136:434–447.
Malige A, Pellegrino AN, Kunkle K, et al. Liposomal bupivacaine in adductor canal blocks before total knee arthroplasty leads to improved postoperative outcomes: a randomized controlled trial. J Arthroplast 2022; 37:1549–1556.
Motakef S, Wong WW, Ingargiola MJ, et al. Liposomal bupivacaine in implant-based breast reconstruction. Plast Reconstr Surg Glob Open 2017; 5:e1559.
Purcell RL, Brooks DI, Steelman TJ, et al. Fascia iliaca blockade with the addition of liposomal bupivacaine versus plain bupivacaine for perioperative pain management during hip arthroscopy: a double-blinded prospective randomized control trial. Arthroscopy 2019; 35:2608–2616.
Simovitch RW, Hernandez T, YaDeau JT, et al. Liposomal bupivacaine plus bupivacaine versus ropivacaine plus dexamethasone brachial plexus blockade for arthroscopic rotator cuff repair: an unblinded randomized controlled trial. J Bone Joint Surg Open Access 2022; 7:e21.00122.
Truong A, Fleshner PR, Mirocha JM, et al. A prospective randomized trial of surgeon-administered intraoperative transversus abdominis plane block with bupivacaine against liposomal bupivacaine: the TINGLE Trial. Dis Colon Rectum 2021; 64:888–898.
Vandepitte C, Kuroda M, Witvrouw R, et al. Addition of liposome bupivacaine to bupivacaine HCl versus bupivacaine HCl alone for interscalene brachial plexus Block in patients having major shoulder surgery. Reg Anesth Pain Med 2017; 42:334–341.
Vandepitte CF, Van Boxstael S, Duerinckx JF, et al. Effect of bupivacaine liposome injectable suspension on sensory blockade and analgesia for Dupuytren contracture release. J Hand Surg Global e 2019; 1:191–197.
Weksler B, Sullivan JL, Schumacher LY. Randomized trial of bupivacaine with epinephrine versus bupivacaine liposome suspension in patients undergoing minimally invasive lung resection. J Thorac Cardiovasc Surg 2021; 161:1652–1661.
Wong KA, Cabrera AG, Argiroff AL, et al. Transversus abdominis plane block with liposomal bupivacaine and its effect on opiate use after weight loss surgery: a randomized controlled trial. Surg Obes Relat Dis 2020; 16:886–893.
Xie D, Nicholson M, Azaiza M, et al. Effect of operative local anesthesia on postoperative pain outcomes of inflatable penile prosthesis: prospective comparison of two medications. Int J Impot Res 2018; 30:93–96.
Yeap YL, Wolfe J, Stewart J, et al. Liposomal bupivacaine addition versus standard bupivacaine alone for colorectal surgery: a randomized controlled trial. Pain Manag 2022; 12:35–43.
Zhang L, Li J, Chen Z. The postoperative analgesia effect of liposome bupivacaine ultrasound-guided PECS blockade after total mammectomy. J Pract Med 2019; 35:3214–3217.
Farrar JT, Young JP, LaMoreaux L, et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001; 94:149–158.
Cepeda MS, Africano JM, Polo R, et al. What decline in pain intensity is meaningful to patients with acute pain? Pain 2003; 105:151–157.
Myles PS, Myles DB, Galagher W, et al. Measuring acute postoperative pain using the visual analog scale: the minimal clinically important difference and patient acceptable symptom state. Br J Anaesth 2017; 118:424–429.
McCann ME. Liposomal bupivacaine: effective, cost-effective, or (Just) costly? Anesthesiology 2021; 134:139–142.
Moayeri N, Bigeleisen PE, Groen GJ. Quantitative architecture of the brachial plexus and surrounding compartments, and their possible significance for plexus blocks. Anesthesiology 2008; 108:299–304.